For instance, peripheral administration of the soluble TNF inhibitor XPro1595 has been shown to rescue impaired LTP in 5xFAD mice, a mouse model of Alzheimer’s disease, together with a decreased beta-amyloid load [51]. This evidence concerns the gene TNF and early-onset autosomal dominant Alzheimer disease.